Navigation Links
Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
Date:1/13/2009

PALO ALTO, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced completion of enrollment in the second of two Phase III pivotal clinical trials of JZP-6 (sodium oxybate) for the treatment of fibromyalgia.

"Completion of enrollment in this second trial is a meaningful milestone in the JZP-6 program in fibromyalgia. We expect to report top-line results from this trial in mid-2009," said Samuel Saks, M.D., Chief Executive Officer.

The JZP-6 Phase III clinical trial program includes two randomized, double blind, placebo-controlled studies. The first study was completed and positive top-line results were announced in November 2008. The second Phase III study has enrolled 575 patients at centers in the U.S. and Europe.

Jazz Pharmaceuticals anticipates submitting a New Drug Application for sodium oxybate to the U.S. Food and Drug Administration by the end of 2009. UCB has the exclusive marketing and distribution rights to sodium oxybate for fibromyalgia in Europe and many other countries outside North America.

About Sodium Oxybate

Sodium oxybate is the sodium salt form of gamma-hydroxybutyrate, an endogenous neurotransmitter and metabolite of GABA. While the precise mechanism of action is unknown, the effects may be mediated in part through interaction with GABA(B) and GHB receptors. Sodium oxybate is the active ingredient in XYREM(R), approved by the FDA for the treatment of excessive daytime sleepiness (EDS) and cataplexy (the sudden loss of muscle tone) in adult patients with narcolepsy. The American Academy of Sleep Medicine recommends sodium oxybate as a standard of care for the U.S. Food and Drug Administration-approved indications. It is also approved by the European Medical Evaluation Agency (EMEA) for the treatment o
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
7. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
(Date:2/26/2015)... Feb. 26, 2015 Research and Markets ... "Radiation Therapy Equipment - Global Strategic Business Report" ... report analyzes the worldwide markets for Radiation Therapy Equipment ... Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The ... Canada , Japan , ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of Hepatitis B virus (HBV) and other viral ... million financing. Funds from this financing will accelerate ... spectrum antiviral agent derived from Spring Bank,s ... platform, into Phase II clinical trials for the ...
Breaking Medicine Technology:National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... standard has replaced the Statement on Auditing Standards No. ... Standards for Attestation Engagements No. 16 (SSAE 16), became ... to enforce a stronger set of controls and more ... Rising Medical Solutions has taken the first ...
... ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced ... Global Healthcare Conference in London. Dr. Ramin Mojdeh, Executive ... to present at 5:00 p.m. British Summer Time (12:00 ... The conference presentation will be broadcast over the ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3Unilife to Present at the Jefferies 2011 Global Healthcare Conference in London 2
(Date:2/27/2015)... According to court documents, Donna Pirolli was a ... and underwent a procedure during which a duodenoscope was ... the duodenoscope allegedly had not been properly cleaned, Donna ... (CRE). , A lawsuit has been proceeding ... of Ms. Pirolli alleging that Lutheran General Hospital was ...
(Date:2/27/2015)... Winter is here, and with it comes harsh snow ... and ice can be harmful on a dog’s paws. Commonly ... Store is ready to help pet owners know what to ... winter time. , Ice melts can lead to several health ... of ice melt products may cause depression, loss of appetite, ...
(Date:2/27/2015)... February 27, 2015 FACE Skincare~Medical~Wellness, ... has announced a unique combination to take fifteen ... Ultherapy Décolletage is a new treatment introduced that ... procedure specifically indicated to improve lines and wrinkles ... any person who suffers from the stubborn vertical ...
(Date:2/27/2015)... California (PRWEB) February 27, 2015 ... announced today the launch of its CloudPoint™ ... enabling the digital production of monolithic zirconia crowns ... affordable means of providing the CAD/CAM-produced restorations that ... digital portal through which cases can be scanned, ...
(Date:2/27/2015)... 2015 Insight Accelerator Labs has ... the development of an in-line urine flow meter ... being developed in direct response to current high ... and error margins with potentially grave consequences. The ... and provide trending data analysis to signal ICU ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... ... ... continuing to offer H1N1 nasal vaccines and H1N1 vaccine shots at four Centegra Primary Care (CPC) ... Huntley, Woodstock, Crystal Lake and McHenry and will be open as follows: , ...
... , ARLINGTON, Va., Nov. 25 The American ... Act of 2009," S. 2128, which is designed to substantially ... The bill was introduced by Sen. George LeMieux (R-Fla.). , ... Homecare outlined in its 13-point anti-fraud action plan, which the ...
... under the skin kill tumor cells, study finds , ... delivered in a fingernail-size implant eliminated melanoma tumors in ... polymer disks, 8.5 millimeters in diameter, that are loaded ... reprogram the immune system to attack tumors. The Harvard ...
... , WASHINGTON, Nov. 25 The Advisory Board ... participate in the 21st Annual Piper Jaffray Health Care Conference ... December 2, 2009 at 3:00 PM (EST), will be the ... Chief Financial Officer, Michael T. Kirshbaum. The presentation materials ...
... , AVENTURA, Fla., Nov. 25 Daniel Touizer, CEO of ... nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the ... without a full-time job and unlikely to have health insurance. ... to 17.5%, the highest rate in over 20 years," says Dani ...
... 25, 2009) Melvin R. Kaplan, MD, FACP, a former ... institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA ... College of Physicians for his lifetime devotion to the care ... Toronto, the American College of Physicians will present Dr. Kaplan ...
Cached Medicine News:Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2
... in diamond technology allow the incredible sharpness ... more economical cost. Proven diamond blade sharpness ... a superior postoperative result. The knives offer ... variety of widths and configurations. The diamonds ...
A Combination Fixation Ring With A Platform Provides A Physiologically Spherical And Low-Reflective Smooth Surface To Place A Reflected Flap For Undersurface Laser Ablation Of The Posterior Flap....
... A Set Of Corneal Gauges Allowing The ... 10.5mm To 13.0mm, With 0.25mm ,Increments.,Easy And ... The Desired Gauge And Place Over A ... Autoclaveable, Made In The USA, ...
... LASIK Marker Has Two ... Evenly Distributed Marks, Providing ... Lamellar Flap To Insure ... Marks Prevent Inadvertent Placement ...
Medicine Products: